Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration.

Optic neuropathy is a major cause of irreversible blindness worldwide, and no effective treatment is currently available. Secondary degeneration is believed to be the major contributor to retinal ganglion cell (RGC) death, the endpoint of optic neuropathy. Partial optic nerve transection (pONT) is an established model of optic neuropathy.

Efficacy and Safety of Human Retinal Progenitor Cells.

Purpose: We assessed the long-term efficacy and safety of human retinal progenitor cells (hRPC) using established rodent models.

Methods: Efficacy of hRPC was tested initially in Royal College of Surgeons (RCS) dystrophic rats immunosuppressed with cyclosporine/dexamethasone. Due to adverse effects of dexamethasone, this drug was omitted from a subsequent dose-ranging study, where different hRPC doses were tested for their ability to preserve visual function (measured by optokinetic head tracking) and retinal structure in RCS rats at 3 to 6 months after grafting.

The structure and development of Xenopus laevis cornea.

The African clawed frog, Xenopus laevis, is a widely used model organism for tissue development. We have followed the process of corneal development closely in Xenopus and examined the corneal ultrastructure at each stage during its formation. Xenopus cornea development starts at stage 25 from a simple embryonic epidermis overlying the developing optic vesicle.